Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:(2S)-1-(dimethylamino)-3-\{4-[(6-\{[2-fluoro-5-(trifluoromethyl)phenyl]amino\}pyrimidin-4-yl)amino]phenoxy\}propan-2-ol
go back to main search page
Accession:CHEBI:39970 term browser browse the term
Definition:An aminopyrimidine that has formula C22H25F4N5O3.


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 833
    chemical entity 833
      atom 817
        nonmetal atom 791
          halogen 257
            fluorine atom 41
              fluorine molecular entity 41
                organofluorine compound 40
                  (2S)-1-(dimethylamino)-3-\{4-[(6-\{[2-fluoro-5-(trifluoromethyl)phenyl]amino\}pyrimidin-4-yl)amino]phenoxy\}propan-2-ol 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 833
    subatomic particle 817
      composite particle 817
        hadron 817
          baryon 817
            nucleon 817
              atomic nucleus 817
                atom 817
                  main group element atom 805
                    main group molecular entity 803
                      s-block molecular entity 683
                        hydrogen molecular entity 676
                          hydrides 310
                            inorganic hydride 203
                              pnictogen hydride 199
                                nitrogen hydride 199
                                  azane 192
                                    ammonia 192
                                      organic amino compound 192
                                        aromatic amine 24
                                          aminopyrimidine 0
                                            (2S)-1-(dimethylamino)-3-\{4-[(6-\{[2-fluoro-5-(trifluoromethyl)phenyl]amino\}pyrimidin-4-yl)amino]phenoxy\}propan-2-ol 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.